Anthera Pharmaceuticals has enrolled half the patients it is seeking for a Phase 3 clinical trial of Sollpura (lipromatase) as treatment…
Articles by Alice Melão, MSc
GeneFo is offering a free online lecture on Sept. 27 about the therapeutic benefits of humor and laughter as strategies…
Chest X-rays commonly used to monitor cystic fibrosis (CF) patients expose these people to cumulative radiation, a known risk for cancer. A…
ProQR Therapeutics has finished a dose-escalating Phase 1b clinical trial evaluating the safety, stability and distribution throughout the body of its…
Fluidigm and Baylor Genetics have teamed up to develop a next-generation gene sequencing method that can quickly identify less…
Two of the three therapies that Proteostasis Therapeutics has developed to correct the underlying problem in cystic fibrosis are going through clinical…
One of the preparations for clinical trials is producing enough of the therapy to be tested. Arch Biopartners says the…
Results of an online survey, conducted by the cystic fibrosis (CF) community GeneFo, showed that a main concern of…
A Phase 3 study of Sollpura (liprotamase), a non-porcine enzyme replacement therapy aiming to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis…
Forty cystic fibrosis patients or family members are winners of Vertex Pharmaceuticals‘ first All in for CF scholarships. The awards…